Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
New hope for breathless patients: inhaled powder aims to ease severe lung condition
Disease control Recruiting nowThis study is testing whether a new once-daily inhaled powder (TPIP) can help adults with a serious lung condition called pulmonary hypertension associated with interstitial lung disease (PH-ILD). The main goal is to see if the treatment improves how far participants can walk in …
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Lifeline extended for patients in lung disease drug trial
Disease control AVAILABLEThis study provides continued access to an inhaled medication called TPIP for people with serious lung and heart conditions. It is for patients who have already successfully completed earlier long-term studies of this drug. The goal is to allow these patients to keep receiving a …
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC